✦ LIBER ✦

Mitochondrial function in Parkinson's disease

✍ Scribed by Prof. Anthony H. V. Schapira; Vincent M. Mann; J. Mark Cooper; David Krige; Peter J. Jenner; C. David Marsden

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 1000 KB
Volume: 32
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410320720

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitochondrial function in Parkinson's di

Mitochondrial function in Parkinson's disease

✍ Fiorenzo Dagani; Jeffrey J. Anderson; Thomas N. Chase 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

Effect of aging and dopaminomimetic ther

Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease

✍ Daniele Bravi; Jeffrey J. Anderson; Fiorenzo Dagani; Thomas L. Davis; Rosaria Fe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

## Abstract Oxygen consumption and enzyme activity were evaluted in platelet mitochondria from 17 patients with Parkinson's disease. In comparison with age‐matched controls, no consistent abnormality could be discerned in complex I, complex II‐III, or complex IV oxygen consumption, or in the enzyme

Mitochondrial abnormalities in Parkinson

Mitochondrial abnormalities in Parkinson's disease

✍ Yoshikuni Mizuno; Shin-Ichirou Ikebe; Nobutaka Hattori; Yuko Nakagawa-Hattori; M 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—mitochondrial abnormalities

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Recently, it was reported that parkinsonlan patients exhibit mitochondrial abnormalhies which might be related to the production of either endogenous or exogenous toxins. We, thus, assessed possible inhibitory effects of dopamine-related compounds on mitochondrial respiration in rat brain. We found

Parkinson's syndrome and Parkinson's dis

Parkinson's syndrome and Parkinson's disease in mitochondrial disorders

✍ Josef Finsterer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract In the majority of cases, mitochondrial disorders are multisystem conditions that most frequently affect the skeletal muscle, followed by the central nervous system. One of the clinical manifestations of central nervous system involvement is Parkinson's syndrome (PS). Evidence for an as

Mitochondrial DNA analysis in Parkinson'

Mitochondrial DNA analysis in Parkinson's disease

✍ Dr. A. H. V. Schapira; I. J. Holt; M. Sweeney; A. E. Harding; P. Jenner; C. D. M 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

## Abstract The reduced form of nicotinamide adenine dinucleotide coenzyme Q reductase (complex I) activity has recently been shown to be deficient in the substantia nigra of patients dying with Parkinson's disease. This biochemical defect is identical to that produced by the neurotoxin 1‐methyl‐4‐